Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to $52.4 million.

  • BridgeBio Pharma's Prepaid Assets rose 3656.27% to $52.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.4 million, marking a year-over-year increase of 3656.27%. This contributed to the annual value of $34.9 million for FY2024, which is 4346.43% up from last year.
  • According to the latest figures from Q3 2025, BridgeBio Pharma's Prepaid Assets is $52.4 million, which was up 3656.27% from $60.2 million recorded in Q2 2025.
  • In the past 5 years, BridgeBio Pharma's Prepaid Assets registered a high of $60.2 million during Q2 2025, and its lowest value of $20.5 million during Q2 2023.
  • Its 5-year average for Prepaid Assets is $31.6 million, with a median of $28.4 million in 2024.
  • As far as peak fluctuations go, BridgeBio Pharma's Prepaid Assets crashed by 3727.18% in 2023, and later skyrocketed by 11214.26% in 2025.
  • Quarter analysis of 5 years shows BridgeBio Pharma's Prepaid Assets stood at $32.3 million in 2021, then plummeted by 32.06% to $21.9 million in 2022, then grew by 10.87% to $24.3 million in 2023, then soared by 43.46% to $34.9 million in 2024, then surged by 50.26% to $52.4 million in 2025.
  • Its last three reported values are $52.4 million in Q3 2025, $60.2 million for Q2 2025, and $35.4 million during Q1 2025.